Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine
Kevin J. Kramer(Vanderbilt University Medical Center), Jonathan M. Irish(Vanderbilt University), Lauren Walker(Vanderbilt University Medical Center), Robert H. Carnahan(Vanderbilt University Medical Center), Sierra Barone(Vanderbilt University), Nagarajan Raju(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Steven C. Wall(Vanderbilt University Medical Center), Debolanle O. Dahunsi(Vanderbilt University Medical Center), Samuel Schaefer, Jeffrey C. Rathmell(University of Chicago), Naveenchandra Suryadevara(Vanderbilt University), Caroline E. Roe(Vanderbilt University), Erin M. Wilfong(Vanderbilt University), Kelsey Voss(University of Virginia), Ivelin S. Georgiev(Vanderbilt University), Camille S. Westlake(University of Virginia), Andrea R. Shiakolas(Vanderbilt University Medical Center), Ariana Paulo(Vanderbilt University Medical Center), Rachel H. Bonami(Vanderbilt University Medical Center)
Cited by 9
Related Papers
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways
|The Journal of Immunology|2008|836